Federal Register / Vol. 66, No. 242 / Monday, December 17, 2001 / Notices 64985

BB. Public Health Nutrition: Masters

level only.

CC. Radiologic Technology: Certificate,

Associate, and B.S.

DD. Respiratory Therapy: Associate.

EE. X-Ray/Ultrasonography.

Interested individuals are reminded

that the list of eligible health and allied

health professions is effective for

applicants for the 2002–2003 academic

year. These priorities will remain in

effect until superseded. Applicants for

health and allied health professions not

on the above priority list will be

considered pending the availability of

funds and dependent upon the

availability of qualified applicants in

the priority areas.

Dated: December 7, 2001.

Michael H. Trujillo,

Assistant Surgeon General, Director, Indian

Health Service.

[FR Doc. 01–30939 Filed 12–14–01; 8:45 am]

BILLING CODE 4160–16–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

Periodically, the Substance Abuse and

Mental Health Services Administration

(SAMHSA) will publish a list of

information collection requests under

OMB review, in compliance with the

Paperwork Reduction Act (44 U.S.C.

Chapter 35). To request a copy of these

documents, call the SAMHSA Reports

Clearance Officer on (301) 443–7978.

National Survey on Drug Use and

Health: Clinical Validation Study of the

Substance Dependence and Abuse

Measures—(New)—The Substance

Abuse and Mental Health Services

Administration’s (SAMHSA) National

Survey on Drug Use and Health

(NSDUH), formerly the National

Household Survey on Drug Abuse, is a

survey of the civilian,

noninstitutionalized population of the

United States 12 years old and older.

The data are used to determine the

prevalence of use of tobacco products,

alcohol, illicit substances, and illicit use

of prescription drugs. The results are

used by SAMHSA, the Office of

National Drug Control Policy, other

Federal government agencies, and other

organizations and researchers to

establish policy, direct program

activities, and better allocate resources.

From 2001–2003, the NSDUH plans a

two-phase Clinical Validation Study of

Substance Dependence and Abuse

Measures. Specific aims are to achieve

the best overarching format, and the best

wording and ordering for the assessment

questions. The goal is quicker

administration time, improved validity,

and reduced respondent burden.

Half of all subject will be between 12

and 17, and half 18 years of age or older;

subjects will be recruited from the

Research Triangle and the Triad areas of

North Carolina. In Phase 1, subjects,

recruited through fliers and newspaper

ads, will be asked (1) demographic

information and (2) questions from two

self-administered sections of the

NSDUH questionnaire: questions about

the quantity and frequency of use of

drugs and alcohol, and questions about

symptoms of substance dependence and

abuse. A semi-structured clinical

interview will then be administered to

these same subjects by a trained

clinician to determine the presence or

absence of substance dependence and

abuse. The clinical instruments used to

assess subjects will be the substance

abuse modules from the Structured

Clinical Interview for DSM–IV (SCID)

(for adults) and the Kiddie Schedule for

Affective Disorders and Schizophrenia

(K–SADS ) (for those between 12 and 17

years of age). The correspondence of the

diagnosis of substance dependence and

abuse between the clinical and survey

interview will then be compared.

Information from Phase 1 will then be

used to assess if a lack of

correspondence exists between the

clinical and survey measures. If there is

a lack of sufficient correspondence, we

will then examine reasons for any lack

of correspondence, and make decisions

about how to modify the NSDUH

questions on substance dependence and

abuse to achieve better correspondence.

This information will then be used to

develop a revised NSDUH substance

dependence and abuse module.

In Phase 2, a second clinical

validation study will be conducted

using the same procedures as Phase 1.

This will allow a determination of the

correspondence (kappa) between the

revised diagnosis obtained from the

NSDUH substance dependence and

abuse module and the diagnosis from

the structured clinical interviews. Final

revisions to the survey instrument will

be made based on findings from Phase

2. All decisions about final revisions to

the module will balance the need for

correspondence across different groups.

The following table summarizes the

total burden associated with this twoyear project.

Number of respondents

Responses

per respondent

Hours per responseTotal burden

hours

Phase I:

Screener only ........................................................................................... 150 1 .08 12

Screener and Interview ............................................................................ 345 1 1.5 518

Phase II:

Screener only ........................................................................................... 300 1 .08 24

Screener and Interview ............................................................................ 595 1 1.5 892

Total ................................................................................................... 1,390 ........................ ........................ 1,446

Annual Average ............................................................................................... 695 ........................ ........................ 723

Written comments and

recommendations concerning the

proposed information collection should

be sent within 30 days of this notice to:

Lauren Wittenberg, Human Resources

and Housing Branch, Office of

Management and Budget, New

Executive Office Building, Room 10235,

Washington, DC 20503.

Dated: December 11, 2001.

Richard Kopanda,

Executive Officer, Substance Abuse and

Mental Health Administration.

[FR Doc. 01–30967 Filed 12–14–01; 8:45 am]

BILLING CODE 4162–20–P